We serve Chemical Name:2-Bromo-3-methylaniline CAS:54879-20-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Bromo-3-methylaniline
CAS.NO:54879-20-8
Synonyms:2-Bromo-3-methylaniline;Benzenamine, 2-bromo-3-methyl-;MFCD06411367
Molecular Formula:C7H8BrN
Molecular Weight:186.049
HS Code:2921430090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:244.7±20.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.609
PSA:26.02000
Exact Mass:184.984009
LogP:2.65
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:2810
Packing Group:
Contact us for information like 2-Bromo-3-methylaniline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD06411367 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Bromo-3-methylaniline Use and application,2-Bromo-3-methylaniline technical grade,usp/ep/jp grade.
Related News: The suit says that while BRAF kinase inhibitors existed prior to Plexxikon’s discoveries, they were not selective, and Plexxikon’s have a core molecular structure that allows them to bind selectively to kinase created by the BRAF mutation. That allows for higher doses to be administered. 5-ethoxy-4,5-dihydro-1,2-oxazole-3-carbonitrile manufacturers There are limited treatment options for the disorder. Women with advanced endometrial cancer who are not candidates for curative therapy have a survival rate of just 17% 5-bromo-3-methylimidazo[4,5-b]pyrazine suppliers The suit says that while BRAF kinase inhibitors existed prior to Plexxikon’s discoveries, they were not selective, and Plexxikon’s have a core molecular structure that allows them to bind selectively to kinase created by the BRAF mutation. That allows for higher doses to be administered. 1,3-DIAMINOACETONE DIHYDROCHLORIDE vendor & factory Just last week, the CDC updated J&J’s label again to warn of “an increased risk” for GBS, although the agency has maintained that a definitive link hasn’t been established. Europe’s medicines regulator added its own warning on Thursday just ahead of ACIP’s meeting. ,The business, home to popular brands such as arthritis gel Voltaren and vitamins line Centrum, generated over £10 billion in sales during 2020.
